Xbrane Biopharma

Xbrane Biopharma is a company listed under the stock ticker XBRANE (SE).

View the org chart displaying its 16 main executives

Most searched biographies at Xbrane Biopharma

• Martin Åmark, Chief Executive Officer and Head of Investor Relati...
• Anders Tullgren, Chairman of the Board
• Kirsti Gjellan, Board Member

Create your alert
to follow the executive moves at Xbrane Biopharma.

Xbrane Biopharma has 2,280 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Xbrane Biopharma

Social media about Xbrane Biopharma

• Xbrane Biopharma on Wikipedia, Google News & Yahoo Finance
• Xbrane Biopharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Martin Åmark

Call Xbrane Biopharma at +46 76...

View the org chart

Register to receive your alert

Report an error